Cerus Corporation

XTRA:CU2 Voorraadrapport

Marktkapitalisatie: €667.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Cerus Toekomstige groei

Future criteriumcontroles 1/6

Cerus is forecast to grow earnings and revenue by 3.1% and 16.1% per annum respectively while EPS is expected to grow by 4.6% per annum.

Belangrijke informatie

3.1%

Groei van de winst

4.6%

Groei van de winst per aandeel

Medical Equipment winstgroei15.8%
Inkomstengroei16.1%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

XTRA:CU2 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2024223-37N/AN/A2
12/31/2023190-37N/A-183
12/31/2022168-40N/A404
9/30/2022158-38-26-25N/A
6/30/2022154-42-30-30N/A
3/31/2022145-49-39-38N/A
12/31/2021131-54-35-34N/A
9/30/2021119-60-43-42N/A
6/30/2021107-61-41-40N/A
3/31/202197-61-41-39N/A
12/31/202092-60-43-42N/A
9/30/202085-62-43-41N/A
6/30/202079-66-62-58N/A
3/31/202076-69-70-63N/A
12/31/201975-71-74-65N/A
9/30/201970-71-73-64N/A
6/30/201968-67-55-47N/A
3/31/201965-62-48-43N/A
12/31/201861-58-32-31N/A
9/30/201861-53-35-34N/A
6/30/201856-52-42-42N/A
3/31/201850-56-46-46N/A
12/31/201744-61-53-52N/A
9/30/201737-63-52-52N/A
6/30/201737-64-56-55N/A
3/31/201737-65-58-57N/A
12/31/201637-63-54-54N/A
9/30/201637-64-53-53N/A
6/30/201635-65N/A-48N/A
3/31/201634-63N/A-48N/A
12/31/201534-56N/A-51N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: CU2 is forecast to remain unprofitable over the next 3 years.

Winst versus markt: CU2 is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: CU2 is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: CU2's revenue (16.1% per year) is forecast to grow faster than the German market (4.6% per year).

Hoge groei-inkomsten: CU2's revenue (16.1% per year) is forecast to grow slower than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if CU2's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven